Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts

Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts

2024 | Emmanuel Kokori, Gbolahan Olatunji, Adeola Akinboade, Aminat Akinoso, Emmanuel Egbunu, Sikiru Ademola Aremu, Chuka Emmanuel Okafor, Olamide Oluwole, Nicholas Aderinto
This paper explores the significant implications of Triple Artemisinin-Based Combination Therapy (TACT) in the global fight against malaria. TACT, an advanced form of Artemisinin-Based Combination Therapy (ACT), addresses resistance, offers a broader spectrum of action, reduces the risk of treatment failure, and can be tailored to regional needs. The TRACII trial demonstrated that TACT is non-inferior to ACT in efficacy and safety, showing reduced reinfection rates. TACT's effectiveness is further supported by studies in regions like Cambodia, Vietnam, and Thailand, where traditional ACT faces multidrug resistance. However, the widespread adoption of TACT depends on accessibility, particularly in resource-limited areas. Collaborative efforts among stakeholders, sustainable pricing, efficient supply chains, and public-private partnerships are crucial for ensuring TACT reaches needy populations. Health education campaigns are essential to dispel myths and promote acceptance. The paper emphasizes the importance of collaboration among governments, international organizations, research institutions, academia, pharmaceutical companies, and local communities to advance the goal of a malaria-free world.This paper explores the significant implications of Triple Artemisinin-Based Combination Therapy (TACT) in the global fight against malaria. TACT, an advanced form of Artemisinin-Based Combination Therapy (ACT), addresses resistance, offers a broader spectrum of action, reduces the risk of treatment failure, and can be tailored to regional needs. The TRACII trial demonstrated that TACT is non-inferior to ACT in efficacy and safety, showing reduced reinfection rates. TACT's effectiveness is further supported by studies in regions like Cambodia, Vietnam, and Thailand, where traditional ACT faces multidrug resistance. However, the widespread adoption of TACT depends on accessibility, particularly in resource-limited areas. Collaborative efforts among stakeholders, sustainable pricing, efficient supply chains, and public-private partnerships are crucial for ensuring TACT reaches needy populations. Health education campaigns are essential to dispel myths and promote acceptance. The paper emphasizes the importance of collaboration among governments, international organizations, research institutions, academia, pharmaceutical companies, and local communities to advance the goal of a malaria-free world.
Reach us at info@study.space